Search

Your search keyword '"Barbagelata, C"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Barbagelata, C" Remove constraint Author: "Barbagelata, C"
40 results on '"Barbagelata, C"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

8. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

14. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

15. Safety of the pulmonary embolism rule‐out criteria rule: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry.

16. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

17. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

18. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

19. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

20. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

21. Timing and characteristics of venous thromboembolism after noncancer surgery

22. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

23. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

24. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

25. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.

26. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

27. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

28. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

29. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

30. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

31. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain,Perfil clínico y satisfacción con el tratamiento anticoagulante en pacientes con fibrilación auricular no valvular atendidos en consultas de medicina interna y neurología de España

32. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

33. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

34. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

35. Timing and characteristics of venous thromboembolism after noncancer surgery

36. Enoxaparin for Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency.

37. Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis.

38. Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis.

39. Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study.

40. Variable expressivity and incomplete penetrance in a large family with non-classical Diamond-Blackfan anemia associated with ribosomal protein L11 splicing variant.

Catalog

Books, media, physical & digital resources